R&D | April 15, 2026
Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
Move amid evidence of widespread reporting gaps
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Subscribe To Our Newsletter & Stay Updated
